Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats-Reference-Cited by-同舟云学术

Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats

Published:2013-03-14 Issue:3 Volume:8 Page:e58275
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Xue-Yuan,Wang Shan-Mei,Li Nan,Hu Yang,Zhang Yuan,Xu Jin-Fu,Li Xia,Ren Jie,Su Bo,Yuan Wei-Zhong,Teng Xin-Rong,Zhang Rong-Xuan,Jiang Dian-hua,Mulet Xavier,Li Hui-Ping

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Global strategy for asthma management and prevention: GINA executive summary;ED Bateman;Eur Respir J,2008

2. Corticosteroid treatment in sarcoidosis;JC Grutters;Eur Respir J,2006

3. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis;JV Peter;BMJ,2008

4. The pulmonary physician in critical care • 6: The pathogenesis of ALI/ARDS;GJ Bellingan;Thorax,2002

5. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients;SR Eachempati;J Trauma,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome;Colloids and Surfaces B: Biointerfaces;2024-05

2. The therapeutic effects of mesenchymal stem cell (MSCs) exosomes in covid-19 disease; Focusing on dexamethasone therapy;Pathology - Research and Practice;2023-11

3. Precise nanodrug delivery systems with cell-specific targeting for ALI/ARDS treatment;International Journal of Pharmaceutics;2023-09

4. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases;Nanomedicine;2022-12

5. Effects of tocilizumab and dexamethasone on the downregulation of proinflammatory cytokines and upregulation of antioxidants in the lungs in oleic acid-induced ARDS;Respiratory Research;2022-09-17